Section 1330.120 Administration of Tests and Therapeutics

TITLE 68: PROFESSIONS AND OCCUPATIONS

CHAPTER VII: DEPARTMENT OF FINANCIAL AND PROFESSIONAL REGULATION

SUBCHAPTER b: PROFESSIONS AND OCCUPATIONS

PART 1330 PHARMACY PRACTICE ACT

SECTION 1330.120 ADMINISTRATION OF TESTS AND THERAPEUTICS

Section 1330.120  Administration of Tests and

Therapeutics

a)         Requirements

1)         A

pharmacist may administer and order tests or therapeutics to persons for the

following conditions:

A)        Influenza;

B)        SARS-CoV-2;

C)        Group A

Streptococcus;

D)        Respiratory

syncytial virus;

E)        Adult-stage

head louse; and

F)         Health

conditions identified by a statewide public health emergency, as defined in the

Illinois Emergency Management Agency Act.

2)

A

pharmacist may delegate the administrative and technical tasks of performing a

test for the health conditions described in this Section to a pharmacy

technician or student pharmacist acting under the supervision of the

pharmacist.

(Section 3(d)(17) of the Act).

3)         Pharmacists

shall practice in accordance with the professional standard of care, consistent

with their education and training.  When assuming new clinical responsibilities

or engaging in specialized areas of practice, pharmacists shall possess the

necessary knowledge and skills to provide safe, effective, and evidence-based

care.  Pharmacists may complete a course of training accredited by the

Accreditation Council of Pharmacy Education (ACPE) to meet this requirement.

4)         The

pharmacist who is responsible for supervising the pharmacy student or pharmacy

technician has the sole responsibility of evaluating the appropriateness of

each test prior to its administration and shall maintain oversight of the

process.

5)         The

pharmacist shall maintain a current Basic Life Support Certification for

Healthcare Providers issued by the American Heart Association, the American Red

Cross, the Health and Safety Institute, or an equivalent as determined by the

Division

sole responsibility of evaluating the appropriateness of

each test prior to its administration and shall maintain oversight of the

process.

5)         The

pharmacist shall maintain a current Basic Life Support Certification for

Healthcare Providers issued by the American Heart Association, the American Red

Cross, the Health and Safety Institute, or an equivalent as determined by the

Division.

6)         Each

pharmacy shall have available a current copy or electronic version of the

current version of the guidelines of the Centers for Disease Control and

Prevention, guidelines of the United States Preventive Services Task Force, or

generally recognized evidence-based clinical guidelines.

7)         The

pharmacist shall ensure that any pharmacy technician or student pharmacist

performing administration of testing, under their direct supervision, has been

appropriately trained and is competent to perform the test safely and

accurately, consistent with the standard of care and manufacturer instructions.

b)         Patient Health History

Intake Form

1)         Prior

to administering testing or therapeutics, a pharmacist shall have the patient

complete a patient health history intake form for the purpose of performing a

patient assessment.

A)        The

patient health history intake form shall include, at a minimum, basic patient

information, including patient contact information, emergency contact

information, history of past and present illness, current medications,

allergies, and patient consent.

B)        Based

upon the results of the patient assessment, the pharmacist shall use their

professional and clinical judgment to determine when a patient should be

referred to the patient's physician or other appropriate health care provider

in lieu of providing testing or therapeutics

tact

information, history of past and present illness, current medications,

allergies, and patient consent.

B)        Based

upon the results of the patient assessment, the pharmacist shall use their

professional and clinical judgment to determine when a patient should be

referred to the patient's physician or other appropriate health care provider

in lieu of providing testing or therapeutics.

2)         Based

on the pharmacists professional and clinical judgment, a referral may be issued

following an initial or follow-up assessment, directing the patient to a

qualified health care provider for further evaluation, diagnosis, or

treatment.  All referrals under this subsection must be provided in writing and

include information advising the patient to seek follow-up care from a health

care provider.

3)         Pharmacists

shall advise patients to consult with the patient's physician or other

appropriate health care provider if their symptoms persist, worsen, or involve

physical manifestations, or if a test comes back as inconclusive or the

treatment plan is unclear.  This disclosure must be documented and signed by

the patient or guardian.

4)         "Therapeutics"

are limited to medications approved by the Food and Drug Administration for the

treatment of health conditions as described in subsection (a)(1) as established

in generally recognized evidence-based clinical guidelines.

"Therapeutics" does not include controlled substances.

c)         Recordkeeping and

Reporting

1)         The

pharmacist shall maintain appropriate records related to the administration of

a test or prescribed therapeutics, including but not limited to:

A)        Information collected

under subsection (b);

B)        Name of

the test or therapeutic administered and the date administered;

C)        Name

and address of the patient's primary health care provider named by the patient,

if known; and

D)        Name

or unique identifier of the administering pharmacist, pharmacy technician, or

student pharmacist

eutics, including but not limited to:

A)        Information collected

under subsection (b);

B)        Name of

the test or therapeutic administered and the date administered;

C)        Name

and address of the patient's primary health care provider named by the patient,

if known; and

D)        Name

or unique identifier of the administering pharmacist, pharmacy technician, or

student pharmacist.

2)         The

pharmacist shall inform the patient's healthcare provider, if known, within a

timely manner after a therapeutic has been dispensed.